Clinical Trials
801
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (337 trials with phase data)• Click on a phase to view related trials
Evaluation of Anti-Xa Activity in Patients With Severe Obesity After Subcutaneous Injection of Enoxaparin for Antithrombotic Prophylaxis at Two Different Sites.
- Conditions
- Venous ThromboembolismObese Patients
- First Posted Date
- 2025-10-09
- Last Posted Date
- 2025-10-09
- Target Recruit Count
- 80
- Registration Number
- NCT07213713
Organoids for Bile Leaks
- Conditions
- Biliary Anastomosis Complication
- Interventions
- Biological: Organoid-guided treatment
- First Posted Date
- 2025-10-09
- Last Posted Date
- 2025-10-09
- Target Recruit Count
- 25
- Registration Number
- NCT07214649
No-Stoma Policy in Advanced Ovarian Cancer Surgery
- Conditions
- Ovary Cancer
- First Posted Date
- 2025-10-08
- Last Posted Date
- 2025-10-08
- Target Recruit Count
- 395
- Registration Number
- NCT07213193
- Locations
- 🇮🇹
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, UOC Ginecologia Oncologica, Roma, Italy
IL-6 and Lactates in Cord Blood and Neonatal Outcomes
- Conditions
- Fetal InfectionFetal Inflammatory Response SyndromeChorioamnionitisChorioamnionitis Affecting Fetus or Newborn
- First Posted Date
- 2025-10-08
- Last Posted Date
- 2025-10-08
- Target Recruit Count
- 160
- Registration Number
- NCT07211503
- Locations
- 🇮🇹
Policlinico Gemelli, Roma, RM, Italy
GLAUcoma Diagnostic and Imaging Analysis (GLAUDIA) Study
- Conditions
- Glaucoma Open-Angle PrimaryOcular Hypertension
- First Posted Date
- 2025-10-07
- Last Posted Date
- 2025-10-07
- Target Recruit Count
- 60
- Registration Number
- NCT07210216
- Prev
- 1
- 2
- 3
- 4
- 5
- 157
- Next
News
EndoZip™ Automated Endoscopic System Shows 11.4% Weight Loss and Improved Comorbidities in Obesity Trial
Interim clinical data from the EndoZip™ automated endoscopic suturing system demonstrated an average total body weight loss of 11.4% at twelve months in patients with class I and II obesity.
Secure Multiparty Computation Enables Privacy-Friendly Evaluation of Patient Data in Adrenal Gland Metastasis Study
A bicenter, prospective, longitudinal observational study utilized MR-guided radiotherapy (MRgRT) to treat adrenal gland metastasis, emphasizing precision and minimizing radiation exposure.
